Sampre Nutritions Receives In-Principle Approval for Preferential Issue

1,770,710 Equity Shares to be issued to promoters.
Rs 7.44 Crore of unsecured debt to be converted into equity.

Reader Takeaway: Debt reduction strengthens balance sheet, but equity dilution impacts existing shareholder earnings per share.

What just happened

Sampre Nutritions Limited has officially received in-principle approval from the BSE for a preferential allotment of 1,770,710 equity shares to its promoter and promoter group. The move is designed to convert Rs 7,43,69,820 of outstanding unsecured loans into company equity at a minimum price of Rs 42 per share.

Why this matters

This debt-to-equity swap is a strategic move to clean up the balance sheet by extinguishing Rs 7.44 crore of liabilities. By converting debt into equity, the company reduces its interest obligations, though it results in the issuance of new shares, which increases the total equity base.

Regulatory and Compliance Notes

The BSE has mandated strict adherence to the Companies Act, 2013, and SEBI (ICDR) Regulations, 2018. The company is required to:

• Ensure allottees refrain from intra-day trading or selling the company's scrip until the allotment date.
• Verify compliance with all SEBI regulations before finalizing the issue.
• File a formal listing application immediately after the allotment process to meet Regulation 14 of the LODR Regulations.

What to track next

Investors should monitor the company’s future filings for the official allotment confirmation and the eventual listing of the newly issued shares on the exchange.